cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Harvard Bioscience Inc
2 own
6 watching
Current Price
$2.11
$0.01
(0.48%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
185.69M
52-Week High
52-Week High
5.56000
52-Week Low
52-Week Low
1.99000
Average Volume
Average Volume
0.32M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization185.69M
icon52-Week High5.56000
icon52-Week Low1.99000
iconAverage Volume0.32M
iconDividend Yield--
iconP/E Ratio--
What does the Harvard Bioscience Inc do?
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Read More
How much money does Harvard Bioscience Inc make?
News & Events about Harvard Bioscience Inc.
Accesswire
1 year ago
NEW YORK, NY / ACCESSWIRE / March 20, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 22-23, 2023. The links can also be found at www.sidoticonference.com/events. Virtual...
Globe Newswire
1 year ago
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21...
Globe Newswire
2years ago
HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the Company) today announced the resignation of Michael Rossi, the Companys chief financial officer and treasurer, effective December 31, 2022. The Company has appointed Jennifer Cote, the Companys vice ...
Globe Newswire
2years ago
HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the Company) today announced financial results for the second quarter ended June 30, 2022. Jim Green, Chairman and CEO, said, "Our second quarter revenues were essentially flat compared to the prior year ...
Globe Newswire
2years ago
Company continues innovating preclinical tools used in new and ongoing small animal research and product development with SmartStudy SmartStudy Technology New Smart Study technology on the Buxco Inhalation System includes a modular tower, FinePointe software and controller for conducting small ...
Frequently Asked Questions
Frequently Asked Questions
What is Harvard Bioscience Inc share price today?
plus_minus_icon
Can Indians buy Harvard Bioscience Inc shares?
plus_minus_icon
How can I buy Harvard Bioscience Inc shares from India?
plus_minus_icon
Can Fractional shares of Harvard Bioscience Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Harvard Bioscience Inc stocks?
plus_minus_icon
What is today’s traded volume of Harvard Bioscience Inc?
plus_minus_icon
What is today’s market capitalisation of Harvard Bioscience Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Harvard Bioscience Inc?
plus_minus_icon
What percentage is Harvard Bioscience Inc down from its 52-Week High?
plus_minus_icon
What percentage is Harvard Bioscience Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.11
$0.01
(0.48%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
GLOBAL PARTNER ACQUISITION-A
GLOBAL PARTNER ACQUISITION-A
$4.50
$0.00 (0.00 %)
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$8.31
$0.35 (4.40 %)
PROQR THERAPEUTICS NV
PROQR THERAPEUTICS NV
$2.63
$0.04 (1.54 %)
CORMEDIX INC
CORMEDIX INC
$8.57
$-0.30 (-3.38 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
GLOBAL PARTNER ACQUISITION-A
GLOBAL PARTNER ACQUISITION-A
$4.50
$0.00 (0.00 %)
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$8.31
$0.35 (4.40 %)
PROQR THERAPEUTICS NV
PROQR THERAPEUTICS NV
$2.63
$0.04 (1.54 %)
CORMEDIX INC
CORMEDIX INC
$8.57
$-0.30 (-3.38 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00